Related Experiment Video
Updated: Jul 28, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular
S Kuriyama1, T Nakatani, K Masui
1Third Department of Internal Medicine, Nara Medical University, Japan.
Abstract:
In the field of gene therapy using retroviral vectors, it appears impossible to introduce a foreign gene into all target cells. Therefore adjacent cell killing, the socalled bystander effect, caused by genetically modified cells provides therapeutic advantages for gene therapy against cancers. We retrovirally transduced the herpes simplex virus thymidine kinase (HSV-tk) gene into murine and rat hepatocellular carcinoma (HCC) cells. These HSV-tk gene-transduced HCC cells were cocultured with the corresponding parental cells in the presence of ganciclovir, at a concentration not at all cytotoxic to the parental cells. When parental HCC cells were cocultured with their HSV-tk gene-transduced counterparts at a high density at which most cells were in contact with one another, they were markedly eliminated. Conversely, when cocultured at a low density at which none of the cells were in contact, a weak but statistically significant bystander effect was observed. Addition of lysates of HSV-tk gene-transduced cells in the presence of ganciclovir did not cause and killing of parental cells. Furthermore, media conditioned by transduced cells with ganciclovir exhibited weak cytotoxic effects on parental cells. These results indicate that cell-cell contact plays a major causative role in the bystander effect and that minor contributors to this phenomenon are some cytotoxic substance released from transduced cells. Importantly, the bystander effect was induced in vivo as well as in vitro. When mixtures of transduced and untransduced HCC cells were implanted into the flank region of mice, intraperitoneal ganciclovir administration considerably inhibited tumor development, indicating the feasibility of gene therapy with HSV-tk gene and ganciclovir against HCC.
Insights
Gene therapy using retroviral vectors can be enhanced by the bystander effect, where modified cells kill adjacent cancer cells. This study shows cell-cell contact is key for this effect in hepatocellular carcinoma treatment.
Area of Science:
- Oncology
- Gene Therapy
- Molecular Biology
Background:
- Gene therapy faces challenges in delivering genes to all target cells.
- The bystander effect, or adjacent cell killing, offers therapeutic potential in cancer gene therapy.
- Herpes simplex virus thymidine kinase (HSV-tk) gene transfer is a strategy for cancer treatment.
Purpose of the Study:
- To investigate the role of cell-cell contact in the bystander effect for hepatocellular carcinoma (HCC) gene therapy.
- To evaluate the therapeutic efficacy of HSV-tk gene transduction and ganciclovir treatment in HCC models.
Main Methods:
- Murine and rat HCC cells were retrovirally transduced with the HSV-tk gene.
- Transduced and parental HCC cells were co-cultured at varying densities in the presence of ganciclovir.
- In vivo studies involved implanting mixtures of transduced and untransduced HCC cells in mice, followed by ganciclovir administration.
Main Results:
- High-density co-culture of HSV-tk transduced and parental HCC cells with ganciclovir led to significant elimination of parental cells.
- Low-density co-culture showed a weaker, but significant, bystander effect.
- Cell lysates and conditioned media from transduced cells showed minimal bystander effect.
- In vivo experiments demonstrated that ganciclovir administration inhibited tumor development in mice bearing mixed HCC cell implants.
Conclusions:
- Cell-cell contact is the primary mechanism driving the bystander effect in HSV-tk/ganciclovir gene therapy for HCC.
- A minor contribution from cytotoxic substances released by transduced cells was observed.
- The HSV-tk/ganciclovir gene therapy approach is feasible for treating hepatocellular carcinoma both in vitro and in vivo.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021